US Stock MarketDetailed Quotes

STOK Stoke Therapeutics

Watchlist
  • 14.630
  • +0.380+2.67%
Close Aug 16 16:00 ET
  • 14.630
  • 0.0000.00%
Post 17:35 ET
770.24MMarket Cap-6741P/E (TTM)

Stoke Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
294.72%4.83M
-18.17%4.22M
-29.22%8.78M
-14.26%2.8M
13.87%3.31M
-176.79%-2.48M
71.73%5.15M
12.41M
3.27M
2.91M
Operating revenue
294.72%4.83M
-18.17%4.22M
-29.22%8.78M
-14.26%2.8M
13.87%3.31M
-176.79%-2.48M
71.73%5.15M
--12.41M
--3.27M
--2.91M
Cost of revenue
Gross profit
Operating expense
11.02%34.17M
9.20%32.59M
5.82%123.55M
6.39%32.39M
1.63%30.54M
8.12%30.78M
7.36%29.84M
35.67%116.76M
24.13%30.44M
32.49%30.05M
Selling and administrative expenses
27.44%13.04M
0.09%10.22M
6.16%41.32M
13.06%10.61M
3.29%10.27M
1.18%10.23M
7.64%10.21M
22.03%38.92M
7.57%9.38M
19.45%9.94M
-General and administrative expense
27.44%13.04M
0.09%10.22M
6.16%41.32M
13.06%10.61M
3.29%10.27M
1.18%10.23M
7.64%10.21M
22.03%38.92M
7.57%9.38M
19.45%9.94M
Research and development costs
2.85%21.14M
13.94%22.37M
5.65%82.23M
3.41%21.78M
0.81%20.27M
11.95%20.55M
7.22%19.63M
43.70%77.84M
33.27%21.06M
40.05%20.11M
Operating profit
11.79%-29.34M
-14.91%-28.37M
-9.98%-114.77M
-8.87%-29.59M
-0.32%-27.23M
-31.79%-33.26M
0.42%-24.69M
-21.25%-104.36M
-10.80%-27.18M
-19.68%-27.15M
Net non-operating interest income expense
43.94%3.7M
15.36%2.43M
217.36%9.91M
74.92%2.59M
166.43%2.65M
371.88%2.57M
1,922.12%2.1M
2,501.67%3.12M
4,008.33%1.48M
2,161.36%995K
Total other finance cost
-43.94%-3.7M
-15.36%-2.43M
-217.36%-9.91M
-74.92%-2.59M
-166.43%-2.65M
-371.88%-2.57M
-1,922.12%-2.1M
-2,501.67%-3.12M
-4,008.33%-1.48M
-2,161.36%-995K
Other net income (expense)
-217.07%-48K
-1,119.05%-428K
-0.60%166K
-2.38%41K
-2.38%41K
-2.38%41K
0.00%42K
19.29%167K
0.00%42K
0.00%42K
Other non- operating income (expenses)
-217.07%-48K
-1,119.05%-428K
-0.60%166K
-2.38%41K
-2.38%41K
-2.38%41K
0.00%42K
19.29%167K
0.00%42K
0.00%42K
Income before tax
16.18%-25.7M
-16.98%-26.37M
-3.59%-104.7M
-5.08%-26.96M
6.01%-24.54M
-24.35%-30.65M
8.54%-22.55M
-17.79%-101.07M
-4.94%-25.66M
-15.55%-26.11M
Income tax
Net income
16.18%-25.7M
-16.98%-26.37M
-3.59%-104.7M
-5.08%-26.96M
6.01%-24.54M
-24.35%-30.65M
8.54%-22.55M
-17.79%-101.07M
-4.94%-25.66M
-15.55%-26.11M
Net income continuous Operations
16.18%-25.7M
-16.98%-26.37M
-3.59%-104.7M
-5.08%-26.96M
6.01%-24.54M
-24.35%-30.65M
8.54%-22.55M
-17.79%-101.07M
-4.94%-25.66M
-15.55%-26.11M
Minority interest income
Net income attributable to the parent company
16.18%-25.7M
-16.98%-26.37M
-3.59%-104.7M
-5.08%-26.96M
6.01%-24.54M
-24.35%-30.65M
8.54%-22.55M
-17.79%-101.07M
-4.94%-25.66M
-15.55%-26.11M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
16.18%-25.7M
-16.98%-26.37M
-3.59%-104.7M
-5.08%-26.96M
6.01%-24.54M
-24.35%-30.65M
8.54%-22.55M
-17.79%-101.07M
-4.94%-25.66M
-15.55%-26.11M
Basic earnings per share
33.33%-0.46
-7.55%-0.57
8.46%-2.38
7.69%-0.6
16.67%-0.55
-9.52%-0.69
19.70%-0.53
-11.11%-2.6
1.52%-0.65
-8.20%-0.66
Diluted earnings per share
33.33%-0.46
-7.55%-0.57
8.46%-2.38
7.69%-0.6
16.67%-0.55
-9.52%-0.69
19.70%-0.53
-11.11%-2.6
1.52%-0.65
-8.20%-0.66
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 294.72%4.83M-18.17%4.22M-29.22%8.78M-14.26%2.8M13.87%3.31M-176.79%-2.48M71.73%5.15M12.41M3.27M2.91M
Operating revenue 294.72%4.83M-18.17%4.22M-29.22%8.78M-14.26%2.8M13.87%3.31M-176.79%-2.48M71.73%5.15M--12.41M--3.27M--2.91M
Cost of revenue
Gross profit
Operating expense 11.02%34.17M9.20%32.59M5.82%123.55M6.39%32.39M1.63%30.54M8.12%30.78M7.36%29.84M35.67%116.76M24.13%30.44M32.49%30.05M
Selling and administrative expenses 27.44%13.04M0.09%10.22M6.16%41.32M13.06%10.61M3.29%10.27M1.18%10.23M7.64%10.21M22.03%38.92M7.57%9.38M19.45%9.94M
-General and administrative expense 27.44%13.04M0.09%10.22M6.16%41.32M13.06%10.61M3.29%10.27M1.18%10.23M7.64%10.21M22.03%38.92M7.57%9.38M19.45%9.94M
Research and development costs 2.85%21.14M13.94%22.37M5.65%82.23M3.41%21.78M0.81%20.27M11.95%20.55M7.22%19.63M43.70%77.84M33.27%21.06M40.05%20.11M
Operating profit 11.79%-29.34M-14.91%-28.37M-9.98%-114.77M-8.87%-29.59M-0.32%-27.23M-31.79%-33.26M0.42%-24.69M-21.25%-104.36M-10.80%-27.18M-19.68%-27.15M
Net non-operating interest income expense 43.94%3.7M15.36%2.43M217.36%9.91M74.92%2.59M166.43%2.65M371.88%2.57M1,922.12%2.1M2,501.67%3.12M4,008.33%1.48M2,161.36%995K
Total other finance cost -43.94%-3.7M-15.36%-2.43M-217.36%-9.91M-74.92%-2.59M-166.43%-2.65M-371.88%-2.57M-1,922.12%-2.1M-2,501.67%-3.12M-4,008.33%-1.48M-2,161.36%-995K
Other net income (expense) -217.07%-48K-1,119.05%-428K-0.60%166K-2.38%41K-2.38%41K-2.38%41K0.00%42K19.29%167K0.00%42K0.00%42K
Other non- operating income (expenses) -217.07%-48K-1,119.05%-428K-0.60%166K-2.38%41K-2.38%41K-2.38%41K0.00%42K19.29%167K0.00%42K0.00%42K
Income before tax 16.18%-25.7M-16.98%-26.37M-3.59%-104.7M-5.08%-26.96M6.01%-24.54M-24.35%-30.65M8.54%-22.55M-17.79%-101.07M-4.94%-25.66M-15.55%-26.11M
Income tax
Net income 16.18%-25.7M-16.98%-26.37M-3.59%-104.7M-5.08%-26.96M6.01%-24.54M-24.35%-30.65M8.54%-22.55M-17.79%-101.07M-4.94%-25.66M-15.55%-26.11M
Net income continuous Operations 16.18%-25.7M-16.98%-26.37M-3.59%-104.7M-5.08%-26.96M6.01%-24.54M-24.35%-30.65M8.54%-22.55M-17.79%-101.07M-4.94%-25.66M-15.55%-26.11M
Minority interest income
Net income attributable to the parent company 16.18%-25.7M-16.98%-26.37M-3.59%-104.7M-5.08%-26.96M6.01%-24.54M-24.35%-30.65M8.54%-22.55M-17.79%-101.07M-4.94%-25.66M-15.55%-26.11M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 16.18%-25.7M-16.98%-26.37M-3.59%-104.7M-5.08%-26.96M6.01%-24.54M-24.35%-30.65M8.54%-22.55M-17.79%-101.07M-4.94%-25.66M-15.55%-26.11M
Basic earnings per share 33.33%-0.46-7.55%-0.578.46%-2.387.69%-0.616.67%-0.55-9.52%-0.6919.70%-0.53-11.11%-2.61.52%-0.65-8.20%-0.66
Diluted earnings per share 33.33%-0.46-7.55%-0.578.46%-2.387.69%-0.616.67%-0.55-9.52%-0.6919.70%-0.53-11.11%-2.61.52%-0.65-8.20%-0.66
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg